Vireo Growth Inc. SEC filings VREOF
Vireo Growth Inc. has 362 filings in SEC EDGAR's recent list, going back to Apr 1, 2019. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, agreement ended, new debt, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Nov 2, 2026 | — |
| S-4/A | Filing | Oct 30, 2026 | — |
| S-4 | Registration for a merger or exchange | Oct 9, 2026 | — |
| S-3 | Shelf registration | Apr 23, 2026 | — |
| 424B3 | Prospectus | Dec 19, 2025 | — |
| S-3 | Shelf registration | Dec 9, 2025 | — |
| 424B3 | Prospectus | Oct 28, 2025 | — |
| S-8 | Employee stock plan registration | Aug 18, 2025 | — |
| 424B3 | Prospectus | Jul 24, 2025 | — |
| S-3 | Shelf registration | Jul 15, 2025 | — |
| 424B3 | Prospectus | Nov 13, 2024 | — |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| S-3/A | Filing | Oct 16, 2024 | — |
| S-3 | Shelf registration | Sep 24, 2024 | — |
| 424B3 | Prospectus | Aug 7, 2024 | — |
| 424B3 | Prospectus | Aug 6, 2024 | — |
| 424B3 | Prospectus | Jul 2, 2024 | — |
| 424B3 | Prospectus | Jun 24, 2024 | — |
| 424B3 | Prospectus | Jun 20, 2024 | — |
| 424B3 | Prospectus | Jun 6, 2024 | — |
| 424B3 | Prospectus | May 10, 2024 | — |
| 424B3 | Prospectus | May 10, 2024 | — |
| 424B3 | Prospectus | May 7, 2024 | — |
| 424B3 | Prospectus | May 6, 2024 | — |
| 424B3 | Prospectus | Apr 29, 2024 | — |
| 424B3 | Prospectus | Apr 17, 2024 | — |
| 424B3 | Prospectus | Apr 5, 2024 | — |
| 424B3 | Prospectus | Apr 3, 2024 | — |
| S-8 | Employee stock plan registration | Apr 3, 2024 | — |
| S-8 | Employee stock plan registration | Apr 3, 2024 | — |
| 424B3 | Prospectus | Mar 11, 2024 | — |
| 424B3 | Prospectus | Dec 12, 2023 | — |
| 424B3 | Prospectus | Dec 7, 2023 | — |
| 424B3 | Prospectus | Dec 7, 2023 | — |
| 424B3 | Prospectus | Dec 7, 2023 | — |
| 424B3 | Prospectus | Dec 7, 2023 | — |
| 424B3 | Prospectus | Aug 22, 2023 | — |
| 424B3 | Prospectus | Aug 15, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| S-1 | Registration statement | Aug 4, 2023 | — |
| S-8 | Employee stock plan registration | Feb 3, 2021 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VREOF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Minneapolis, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1771706
- Former names
- Goodness Growth Holdings, Inc. (until Jun 24, 2024); Vireo Health International, Inc. (until May 14, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.